Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,060,000 shares, an increase of 17.9% from the February 13th total of 899,200 shares. Based on an average daily trading volume, of 13,030,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 13.5% of the shares of the stock are sold short.

Institutional Trading of Sharps Technology

Several hedge funds have recently bought and sold shares of the stock. Anson Funds Management LP purchased a new stake in Sharps Technology in the 4th quarter worth $76,000. Essential Planning LLC. lifted its stake in Sharps Technology by 22.7% in the 4th quarter. Essential Planning LLC. now owns 199,854 shares of the company’s stock worth $412,000 after purchasing an additional 37,029 shares in the last quarter. Finally, Garden State Investment Advisory Services LLC purchased a new stake in Sharps Technology in the 3rd quarter worth $26,000. Hedge funds and other institutional investors own 17.17% of the company’s stock.

Sharps Technology Stock Performance

STSS opened at $0.35 on Wednesday. Sharps Technology has a fifty-two week low of $0.25 and a fifty-two week high of $18.15. The company’s fifty day moving average price is $0.78. The stock has a market cap of $1.90 million, a PE ratio of -0.04 and a beta of 1.47.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.